3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
6
Observational
1
Sponsor
Conditions
Breast Neoplasms
5
Hyperglycemia
1
Hereditary Sensory and Autonomic Neuropathies
1
Interventions
pembrolizumab
1
Pharmaceutical Preparations
1
Nivolumab
1
Alpelisib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Hereditary Sensory and Autonomic Neuropathies
×
Alpelisib
×
Clear all
NCT04285723
2023-02-09
EPIK-P1
Novartis
Completed
57 enrolled
23 charts
1 FDA